RHEUMATOID ARTHRITIS AND LYME DISEASE--T CELL RECEPTOR
类风湿性关节炎和莱姆病--T细胞受体
基本信息
- 批准号:3457027
- 负责人:
- 金额:$ 11.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1988
- 资助国家:美国
- 起止时间:1988-07-01 至 1993-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
T cells appear to play a role in the pathogenesis of rheumatoid
arthritis although there has been no demonstration of T cell
reactivity to putative disease-related antigens.
Recent advances in the understanding of the structure and
genetics of the T cell antigen-receptor have made available new
approaches to the study of T cell specificity. In this proposal T
cell clones will be derived from the synovial space (SS) of a well
defined subset of RA patients, i.e. classical or definite RA with
proliferative synovitis. The disease-specific T cell clones will be
identified from among the heterogeneous clones derived from this
site of inflammation on the basis of finding a clonal or oligoclonal
distribution of antigen receptor gene rearrangements. T cells
derived from the SS of patients with Lyme arthritis will be
similarly studied as a model in which the disease related antigen
is known.
Interleukin-2 dependent T cell clones from the SS and the
peripheral blood will be derived from patients with Lyme arthritis
and RA. In the case of Lyme arthritis, T cell clones will be grown
with the causative agent, B. burgdorferi. In addition, T cell
clones will be grown in parallel with anti-T3 antibody to further
confirm that anti-T3 antibody can maintain the antigen-
specificity of T cell lines grown in the absence of specific
antigens. In the case of RA, T cell clones will be grown only with
anti-T3 antibody. T cell receptor rearrangements utilized by
these T cell clones will be studied by using Southern blot analysis
(including pulse-field electrophoresis for the alpha chain) and
DNA sequencing.
The long-term goal of the present proposal is to identify the
disease-specific T cells derived from the synovial space in RA and
generate monoclonal antibodies directed toward the T cell
receptor on such cells. Such antibodies would be of theoretical,
diagnostic, and perhaps therapeutic significance.
T细胞似乎在类风湿的发病机制中起作用
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN J PADULA其他文献
STEVEN J PADULA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN J PADULA', 18)}}的其他基金
RHEUMATOID ARTHRITIS AND LYME DISEASE--T CELL RECEPTOR
类风湿性关节炎和莱姆病--T细胞受体
- 批准号:
3457026 - 财政年份:1988
- 资助金额:
$ 11.09万 - 项目类别:
RHEUMATOID ARTHRITIS AND LYME DISEASE--T CELL RECEPTOR
类风湿性关节炎和莱姆病--T细胞受体
- 批准号:
3457024 - 财政年份:1988
- 资助金额:
$ 11.09万 - 项目类别:
RHEUMATOID ARTHRITIS AND LYME DISEASE--T CELL RECEPTOR
类风湿性关节炎和莱姆病--T细胞受体
- 批准号:
3457028 - 财政年份:1988
- 资助金额:
$ 11.09万 - 项目类别:
RHEUMATOID ARTHRITIS AND LYME DISEASE--T CELL RECEPTOR
类风湿性关节炎和莱姆病--T细胞受体
- 批准号:
3457025 - 财政年份:1988
- 资助金额:
$ 11.09万 - 项目类别:
FEASIBILITY STUDY--SHARED IDIOTYPES TO IDENTIFY HUMAN T-CELL ANTIGEN RECEPTOR
可行性研究——鉴定人类 T 细胞抗原受体的共享独特型
- 批准号:
4689359 - 财政年份:
- 资助金额:
$ 11.09万 - 项目类别:
相似海外基金
Analysis of the role of CD3 molecule expressing in germinal center B cells
生发中心B细胞表达CD3分子的作用分析
- 批准号:
26860327 - 财政年份:2014
- 资助金额:
$ 11.09万 - 项目类别:
Grant-in-Aid for Young Scientists (B)